References
- Palazzi D, Klein J, Baker C. Bacterial sepsis and meningitis. In: Remington J, Klein J, Wilson C, Baker C, eds. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Elsevier Saunders; 2006:247–95
- Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centres for Disease Control and Prevention (CDC). Prevention of perinatal group B Streptococcal disease – revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1–36
- Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J 2011;30:937–41
- Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817–26
- National Institute for Health and Clinical Excellence. Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. (CG102). London: NICE; 2012. Available from: http://guidance.nice.org.uk/CG149/Guidance/pdf/English [last accessed 13 Sep 2013]
- Mukhopadhyay S, Puopolo KM. Risk assessment in neonatal early onset sepsis. Semin Perinatol 2012;36:408–15
- Hsu KK, Pelton SI, Shapiro DS. Detection of group B Streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis 2003;45:23–7
- Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22:430–4
- Newman TB, Puopolo KM, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010;126:903–9
- Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012;102:25–36
- Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants ≥2000 grams at birth: a population-based study. Pediatrics 2000;106:256–63
- Brady MT, Polin RA. Prevention and management of infants with suspected or proven neonatal sepsis. Pediatrics 2013;132:166–8
- Berardi A, Lugli L, Rossi C, et al.; GBS Prevention Working Group, Emilia-Romagna. Impact of perinatal practices for early-onset group-B streptococcal disease prevention. Pediatr Infect Dis J 2013;32:e265–71
- Berardi A, Lugli L, Baronciani D, et al.; GBS Prevention Working Group of Emilia-Romagna. Group B Streptococcus early-onset disease in Emilia-Romagna: review after introduction of a screening-based approach. Pediatr Infect Dis J 2010;29:115–22
- Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG 2006;113:758–65
- Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobialprophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003;3:201–13
- Alm B, Erdes L, Möllborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008;121:697–702
- Cantoni L, Ronfani L, Da Riol R, Demarini S. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention's 2010 Recommendations. J Pediatr 2013;163:568–73
- Berardi A, Lugli L, Baronciani D, et al.; GBS Prevention Working Group of Emilia-Romagna. Group B Streptococcal infections in a Northern region of Italy. Pediatrics 2007;120:e487–93